Pediatrix Medical Group, Inc. (NYSE:MD) Given Average Rating of “Hold” by Brokerages

Pediatrix Medical Group, Inc. (NYSE:MD) has received a consensus recommendation of “Hold” from the seven brokerages that are presently covering the firm, Marketbeat.com reports. Five research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $24.3333.

Several research analysts recently issued reports on MD shares. UBS Group increased their price objective on Pediatrix Medical Group from $22.00 to $25.00 and gave the stock a “neutral” rating in a research note on Tuesday, May 12th. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $25.00 price target on shares of Pediatrix Medical Group in a research note on Wednesday. Jefferies Financial Group reiterated a “buy” rating and set a $27.00 target price on shares of Pediatrix Medical Group in a report on Monday, April 20th. Truist Financial upped their price target on shares of Pediatrix Medical Group from $23.00 to $28.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. Finally, Weiss Ratings raised shares of Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a report on Tuesday.

Insider Transactions at Pediatrix Medical Group

In other news, Director Shirley A. Weis sold 36,028 shares of Pediatrix Medical Group stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $23.75, for a total value of $855,665.00. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 1.80% of the company’s stock.

Institutional Investors Weigh In On Pediatrix Medical Group

Hedge funds have recently made changes to their positions in the stock. Global Retirement Partners LLC grew its stake in Pediatrix Medical Group by 68,250.0% in the fourth quarter. Global Retirement Partners LLC now owns 1,367 shares of the company’s stock valued at $29,000 after purchasing an additional 1,365 shares during the last quarter. Transamerica Financial Advisors LLC purchased a new stake in shares of Pediatrix Medical Group during the fourth quarter valued at about $30,000. Eurizon Capital SGR S.p.A. bought a new stake in shares of Pediatrix Medical Group in the 4th quarter valued at about $33,000. Blue Trust Inc. bought a new stake in shares of Pediatrix Medical Group in the 4th quarter valued at about $37,000. Finally, TD Private Client Wealth LLC purchased a new position in shares of Pediatrix Medical Group in the 4th quarter worth approximately $39,000. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Pediatrix Medical Group Trading Up 5.5%

Shares of MD opened at $26.07 on Thursday. The firm has a market capitalization of $2.14 billion, a price-to-earnings ratio of 12.47 and a beta of 0.66. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.19 and a quick ratio of 1.33. Pediatrix Medical Group has a 1-year low of $12.95 and a 1-year high of $27.94. The company has a 50-day moving average of $24.85 and a 200 day moving average of $22.56.

Pediatrix Medical Group (NYSE:MD) last issued its earnings results on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, topping analysts’ consensus estimates of $0.59 by $0.04. Pediatrix Medical Group had a net margin of 8.96% and a return on equity of 20.05%. The business had revenue of $487.78 million for the quarter, compared to analyst estimates of $478.49 million. During the same period last year, the company posted $0.53 earnings per share. The company’s quarterly revenue was up 4.1% compared to the same quarter last year. On average, research analysts expect that Pediatrix Medical Group will post 2.1 EPS for the current year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.